Effects on co-administration of FLT3 ligand with GM-CSF or G-CSF murine bone marrow and peripheral blood CFU.

被引：0
|
作者：
Brasel, K [1 ]
McKenna, HJ [1 ]
Williams, DE [1 ]
Lyman, SD [1 ]
机构：
[1] IMMUNEX CORP,SEATTLE,WA
来源：
BLOOD | 1996年 / 88卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：3619 / 3619
页数：1
相关论文
共 50 条
  • [1] Studies of FLT3 ligand alone and in combination with GM-CSF or G-CSF in healthy volunteers.
    Lebsack, ME
    Hoek, J
    Feng, A
    Caron, D
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1999, 65 (02) : 193 - 193
  • [2] Comparison of the functional properties of murine dendritic cells generated in vivo with Flt3 ligand, GM-CSF and Flt3 ligand plus GM-CSF
    Daro, E
    Butz, E
    Smith, J
    Teepe, M
    Maliszewski, CR
    McKenna, HJ
    CYTOKINE, 2002, 17 (03) : 119 - 130
  • [3] Synergistic effects in vivo of FLT3 ligand with GM-CSF or G-CSF in mobilization of colony forming cells in mice.
    Brasel, K
    McKenna, HJ
    Charrier, K
    Morrissey, P
    Williams, DE
    Lyman, SD
    BLOOD, 1995, 86 (10) : 1986 - 1986
  • [4] In vivo administration of Flt3 ligand but not G-CSF nor GM-CSF results in the generation of large numbers of dendritic cells in mice.
    Maraskovsky, E
    McKenna, HJ
    Brasel, K
    Tepee, M
    Roux, E
    Lyman, SD
    Williams, DE
    BLOOD, 1995, 86 (10) : 1680 - 1680
  • [5] THE USE OF G-CSF AND GM-CSF IN BONE-MARROW TRANSPLANTATION
    BOLWELL, BJ
    CLEVELAND CLINIC JOURNAL OF MEDICINE, 1993, 60 (04) : 291 - 302
  • [6] Sequential administration of GM-CSF followed by G-CSF after allogeneic bone marrow transplantation [BMT].
    Jaimovich, G
    Feldman, L
    Milovic, V
    Gabai, E
    Freigeiro, D
    Drelichman, G
    BLOOD, 1995, 86 (10) : 3789 - 3789
  • [7] A multifunctional agonist of the G-CSF and FLT3 receptors has greater stem cell mobilizing activity than co-administration of G-CSF and FLT3L.
    Fleming, WH
    Mulcahy, JM
    McKearn, JP
    Streeter, PR
    BLOOD, 1999, 94 (10) : 49A - 49A
  • [8] OPTIMAL PERIPHERAL-BLOOD STEM-CELL (PBSC) MOBILIZATION WITH GM-CSF OR G-CSF NECESSITATES CHEMOTHERAPY PRIMING - A STUDY OF GM-CSF OR G-CSF ALONE COMPARED TO GM-CSF OR G-CSF PLUS CYTOXAN (CY)
    KOUIDES, PA
    ABBOUD, CN
    KOUIDES, RW
    FREDIANI, KE
    BELANGER, T
    DIPERSIO, JF
    BLOOD, 1993, 82 (10) : A634 - A634
  • [9] Randomized phase II study of FLT3 ligand (Mobist™) in combination with GM-CSF or G-CSF for mobilization of peripheral blood progenitor cells in patients with lymphoma or ovarian cancer.
    Stiff, PJ
    Beveridge, RA
    Vose, J
    Fay, J
    Schuster, MW
    Geller, RB
    Caron, D
    Lebsack, ME
    BLOOD, 1999, 94 (10) : 666A - 666A
  • [10] Mobilization of peripheral blood progenitor cells for autografting: chemotherapy and G-CSF or GM-CSF
    Siena, S
    Bregni, M
    Gianni, AM
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 1999, 12 (1-2) : 27 - 39
12345